Quantcast
Last updated on May 19, 2013 at 9:20 EDT

Latest dialysis Stories

2012-10-11 04:01:52

Reich & Binstock, LLP is currently investigating claims against Fresenius Medical Care AG, the makers of dialysis products GranuFlo® and NaturaLyte®. These products have been linked to causing alkalosis, a condition associated with an increase in cardiovascular death and catastrophic cardiovascular injuries in patients undergoing dialysis. Houston, Texas (PRWEB) October 10, 2012 Reich & Binstock, LLP, a Houston-based law firm, is currently investigating claims against...

2012-10-09 21:48:24

Results help explain serious health, dietary complications in renal failure patients Chronic kidney disease changes the composition of intestinal bacterial microbes that normally play a crucial role in staving off disease-causing pathogens and maintaining micronutrient balance, according to UC Irvine researchers. This profound alteration of the gut microbial population may contribute to the production of uremic toxins, systemic and local inflammation, and nutritional abnormalities...

2012-10-08 15:22:51

LAWRENCE, Mass., Oct. 8, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Founder and Chief Executive Officer of NxStage, accepted Home Dialyzors United's (HDU) Trailblazer Award for NxStage's outstanding achievement in the innovation and advancement of home hemodialysis with the NxStage System One(TM), at the HDU's 3(rd) Annual Meet Up and Conference in Baltimore, MD. In...

2012-10-05 23:00:26

Wright & McGurk is warning dialysis patients that they could be at risk for potentially fatal consequences associated with two recently recalled dialysis solutions. Orange County, CA (PRWEB) October 05, 2012 Wright & McGurk is warning dialysis patients that they could be at risk for potentially fatal injuries as a result of dialysis treament. Patients who received dialysis treatments using Fresenious Medical Care’s (FMC) products GranuFlo or NaturaLyte could be at serious risk...

2012-10-05 10:21:42

LAWRENCE, Mass., Oct. 5, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on a review article published on October 4 in the Clinical Journal of the American Society of Nephrology (CJASN) in which leading nephrologists advocate for broadened access to home hemodialysis based on its proven benefits and successful use by thousands of patients. Within the paper, "How to Overcome Barriers and Establish a...

2012-10-05 14:40:14

Highlights: -Home hemodialysis could allow patients to enjoy increased freedom, quality of life, greater ability to travel, and tangible health improvements. -Increased physician and patient education can eliminate barriers to home hemodialysis and increase its use. Approximately 2 million patients in the world receive some sort of dialysis treatment. Most patients with chronic kidney disease who undergo hemodialysis put up with a grueling treatment regimen that involves going into...

2012-10-04 10:24:09

NEW YORK, Oct. 4, 2012 /PRNewswire/ -- Like many of her students, Jennifer Messmer is a career changer. She had been working as a hemodialysis nurse/transplant coordinator for a New York hospital before enduring several traumatic hand surgeries, which made it difficult for her to continue her career. "I saw an ad in the paper for a dialysis instructor at Star Career Academy, applied and was hired," she said. "One door closed and look what opened - a whole new world that I just...

2012-10-04 02:27:25

LITTLE FALLS, N.J., Oct. 4, 2012 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMN) will release the results for its fourth quarter and fiscal year ended July 31, 2012 on Thursday, October 11 before the market opens, and hold a conference call to discuss the results at 11:00 AM EDT. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO; and Craig A. Sheldon, Senior Vice President, CFO and Treasurer. To participate in the conference call,...

2012-10-03 23:01:38

Per the FDA, Fresenius Medical Care failed to notify its entire client base of its product’s adverse side effects Cleveland, OH (PRWEB) October 03, 2012 Cleveland, Ohio, law firm Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly suffered heart problems, cardiac arrest, or death while undergoing kidney dialysis using Fresenius Medical Care’s GranuFlo or NaturaLyte products. fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm...

2012-10-02 10:28:27

CHICAGO and DENVER, Oct. 2, 2012 /PRNewswire/ -- Flexpoint Ford, LLC ("Flexpoint"), a private equity firm focused on the healthcare and financial services sectors, and Corva, LLC ("Corva") announced today that Corva has signed a definitive agreement to acquire the assets of Innovative Renal Care ("IRC"). Corva is a new partnership between Flexpoint, Jerry Simonsen and other senior managers that is focused on acquiring, developing, and operating dialysis clinics. IRC is located...